Skip to main content

Table 12 Risk factors for venous thromboembolism in cancer patients

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

Variable

β coefficient

SE

P value

1 Cisplatin based chemotherapy

1.034

0.35

0.003

2 Age (years)

0.01

0.015

0.42

3 ECOG poor

0.79

0.44

0.07

4 Female

0.41

0.31

0.19

5 GCSF never

0

  

   < 50% of the cycles

0.13

0.37

 

   > 50% of the cycles

0.87

0.45

 

  all

0.15

0.51

0.17

6 Stage early

0

  

  locally advanced

−0.42

0.63

 

  metastatic

−0.17

0.61

0.67

7 CVC present

0.74

0.31

0.01

8 Khorana Risk low

0

 

0.07

  intermediate

−0.91

0.46

 

  high

−0.85

0.37